tiprankstipranks
Trending News
More News >
Consun Pharmaceutical Group Ltd. (DE:C1P)
FRANKFURT:C1P
Advertisement

Consun Pharmaceutical Group Ltd. (C1P) Price & Analysis

Compare
2 Followers

C1P Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
New Product DevelopmentPotential introduction of new drugs, with focus areas being identified, could be a catalyst and drive sales growth ahead.
Risk ReductionRecent exclusion in the national tender of finished Chinese medicines indicates lower risk on price cut for its key product uremic clearance granule (UCG) in the next 2 years.
Bears Say
Economic ImpactSales volume growth slowdown due to a slowing economy.

Consun Pharmaceutical Group Ltd. News

C1P FAQ

What was Consun Pharmaceutical Group Ltd.’s price range in the past 12 months?
Consun Pharmaceutical Group Ltd. lowest stock price was €0.59 and its highest was €1.49 in the past 12 months.
    What is Consun Pharmaceutical Group Ltd.’s market cap?
    Consun Pharmaceutical Group Ltd.’s market cap is €1.36B.
      When is Consun Pharmaceutical Group Ltd.’s upcoming earnings report date?
      Consun Pharmaceutical Group Ltd.’s upcoming earnings report date is Apr 01, 2026 which is in 213 days.
        How were Consun Pharmaceutical Group Ltd.’s earnings last quarter?
        Consun Pharmaceutical Group Ltd. released its earnings results on Aug 19, 2025. The company reported €0.069 earnings per share for the quarter, beating the consensus estimate of N/A by €0.069.
          Is Consun Pharmaceutical Group Ltd. overvalued?
          According to Wall Street analysts Consun Pharmaceutical Group Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Consun Pharmaceutical Group Ltd. pay dividends?
            Consun Pharmaceutical Group Ltd. does not currently pay dividends.
            What is Consun Pharmaceutical Group Ltd.’s EPS estimate?
            Consun Pharmaceutical Group Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Consun Pharmaceutical Group Ltd. have?
            Consun Pharmaceutical Group Ltd. has 852,617,400 shares outstanding.
              What happened to Consun Pharmaceutical Group Ltd.’s price movement after its last earnings report?
              Consun Pharmaceutical Group Ltd. reported an EPS of €0.069 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.154%.
                Which hedge fund is a major shareholder of Consun Pharmaceutical Group Ltd.?
                Currently, no hedge funds are holding shares in DE:C1P

                Consun Pharmaceutical Group Ltd. Stock Smart Score

                Company Description

                Consun Pharmaceutical Group Ltd.

                Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; and Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, tonics, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.

                Consun Pharmaceutical Group Ltd. (C1P) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                China Traditional Chinese Medicine Holdings Co
                Sihuan Pharmaceutical Holdings Group
                YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
                China Shineway Pharmaceutical Group Limited
                Shandong Xinhua Pharmaceutical Company Limited Class H

                Ownership Overview

                6.79%91.64%
                Insiders
                6.79%
                Mutual Funds
                ― Other Institutional Investors
                91.64% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis